Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Afatinib impurity 36 is a chemical impurity associated with the drug Afatinib, an irreversible ErbB receptor tyrosine kinase inhibitor. This impurity is utilized in the analytical assessment of Afatinib’s purity and quality, aiding in the development and validation of pharmaceutical formulations. Its identification is essential for maintaining compliance with regulatory standards in drug manufacturing. -
Drug Intermediate
(1R,2R)-2-(4-Bromobenzoyl)cyclopentane-1-carboxylic acid serves as a valuable drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of various therapeutic agents through its ability to participate in key chemical reactions. Its unique structure and functional groups make it an essential building block for researchers in pharmaceutical chemistry and drug discovery. -
Drug Impurity
Cannabidiol impurity 1 is a known impurity derived from Cannabidiol. This compound is often identified during the analysis and purification processes of Cannabidiol formulations. Its presence can impact the purity and potency of cannabinoid products, making it relevant for quality control and regulatory compliance in pharmaceutical and nutraceutical research. -
Drug Intermediate
tert-Butyl 3-(1-amino-2-methylpropan-2-yl)-1H-indole-1-carboxylate is a drug intermediate utilized in the synthesis of diverse pharmacologically active compounds. This compound serves as a key building block in medicinal chemistry, facilitating the development of novel therapeutic agents. Its structure can be leveraged in research applications focused on drug discovery and design. -
Drug Impurity
6,7-Dihydropyrazino[2,3-d]pyridazine-5,8-dione is identified as a drug impurity that may arise during the synthesis of pharmaceutical compounds. Its presence can impact the purity and safety profile of drug formulations. This compound is important for research applications that focus on the characterization and quantification of impurities in drug development and quality control processes. -
Drug Intermediate
(R)-1,4-Dibenzyl-2-(chloromethyl)piperazine serves as a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical compounds. Its structural characteristics enable chemists to leverage this reagent in various synthetic pathways. This compound is essential for producing molecules with potential therapeutic applications in medicinal chemistry research. -
Drug Intermediate
5-Methoxyquinolin-8-amine is a synthetic intermediate primarily utilized in the preparation of N-phthaloyl amino acid derivatives. This compound serves as a valuable building block in organic synthesis, facilitating the development of various bioactive molecules. Its unique structural features make it a crucial reagent in pharmaceutical research and development applications. -
Drug Intermediate
tert-Butyl (trans-3-(pyridin-4-yloxy)cyclobutyl)carbamate serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This reagent is instrumental in medicinal chemistry for the development of novel therapeutics through various synthetic pathways. Its unique structure facilitates specific interactions, making it valuable for investigations in pharmaceutical research. -
Drug Impurity
Butenafine impurity 2 is a drug impurity related to Butenafine, a compound primarily used as an antifungal agent. This impurity can be crucial for analytical studies and quality control in pharmaceutical development. Its characterization helps ensure the safety and efficacy of Butenafine formulations in research and clinical applications. -
Drug Intermediate
Thiophene-2-amidoxime is a synthetic compound that serves as a valuable intermediate in pharmaceutical synthesis. This reagent plays a critical role in the preparation of bioactive molecules, facilitating the development of novel therapeutic agents. Its unique chemical structure makes it suitable for various chemical transformations in drug discovery and development processes. -
Drug Impurity
Atenolol impurity 5 (p-Hydroxy pheny lacetamide) serves as a drug impurity of Atenolol. This compound is significant for analytical chemistry applications, particularly in the quality control and pharmacokinetic studies of Atenolol formulations. It aids in assessing the purity and safety profiles of Atenolol and can be utilized in method development for impurity identification and quantification. -
Drug Intermediate
5-Bromo-2-chloro-N-ethylpyrimidin-4-amine serves as a crucial drug intermediate in pharmaceutical synthesis. It is utilized in the preparation of various bioactive compounds, making it valuable for medicinal chemistry research and development. Its structural attributes enable modifications that can lead to the discovery of new therapeutic agents. -
Drug Intermediate
2-Acetoxyacetic acid serves as a valuable drug intermediate in the synthesis of truncated sidroxil derivatives. Its unique chemical structure facilitates various chemical reactions crucial in pharmaceutical research and development. This compound is essential for synthesizing complex molecules, aiding in the exploration of therapeutic options within medicinal chemistry. -
Drug Intermediate
8-Chloroisoquinolin-3(2H)-one serves as a critical drug intermediate in the synthesis of various bioactive compounds. This compound is instrumental for researchers focused on developing pharmaceuticals targeting a range of biological pathways. Its unique structure enables diverse applications in medicinal chemistry and drug discovery research. -
Drug Intermediate
Diphenylmethane functions as a key drug intermediate in pharmaceutical synthesis. Its aromatic structure allows for versatile applications, including use as an oxidizing agent in the fragrance industry, a synergist in pesticides, and a plasticizer in dye formulations. This compound plays an essential role in enhancing the efficacy of various chemical processes, making it valuable across multiple research applications in organic and medicinal chemistry. -
Drug Intermediate
Tert-Butyl (R)-2-(3-(3-(3,4-dimethoxyphenyl)-1-hydroxypropyl)phenoxy)acetate serves as a key drug intermediate in the synthesis of various bioactive compounds. Its structural components facilitate modifications that are crucial for developing targeted therapeutics. This reagent is essential in medicinal chemistry and structure-activity relationship studies, enabling researchers to explore novel pharmaceutical agents. -
Drug Intermediate
Pyrimidin-4-yl-methanol is a synthetic intermediate commonly utilized in pharmaceutical synthesis. It serves as a crucial building block for the construction of various biologically active compounds. This reagent is significant for drug development, particularly in the creation of therapeutic agents targeting diverse diseases. -
Drug Intermediate
tert-Butyl 1-(hydroxymethyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate hydrochloride serves as a key drug intermediate in the synthesis of various biologically active compounds. This reagent facilitates the development of pharmacologically relevant molecules, contributing to research in medicinal chemistry and drug discovery. Its unique structural features enable the exploration of diverse chemical pathways and enhance the understanding of therapeutic potentials. -
Drug Intermediate
9-Acetyl-7-methyl-2-morpholin-4-ylpyrido[1,2-a]pyrimidin-4-one serves as a valuable drug intermediate in the synthesis of diverse bioactive compounds. This compound is utilized in pharmaceutical research and development, facilitating the creation of novel therapeutics through its unique structural properties. Its role in medicinal chemistry makes it a crucial component for drug design and optimization efforts. -
Drug Intermediate
3-Bromo-4-chlorobenzoic acid is a key drug intermediate utilized in the synthesis of various active pharmaceutical compounds. Its structural attributes facilitate the development of targeted therapeutic agents, enhancing research in medicinal chemistry. This compound serves as a valuable building block for the advancement of novel pharmaceuticals. -
Drug Intermediate
5-Methylthiazol-2-amine hydrochloride serves as a crucial drug intermediate, playing a significant role in the synthesis of diverse active pharmaceutical compounds. This reagent is essential for research involving thiazole derivatives and their biological activities, promoting advancements in medicinal chemistry and drug discovery applications. Its utility in the development of novel therapeutics makes it a valuable resource for researchers focused on pharmaceutical development. -
Drug Intermediate
4-Acetoxycinnamic acid is an acetate ester derived from the condensation of the hydroxy group of trans-4-coumaric acid with acetic acid. This compound belongs to the cinnamic acid family and the phenyl acetate class. 4-Acetoxycinnamic acid is primarily utilized as a drug intermediate, facilitating the synthesis of various pharmaceutical compounds, and is of interest in research related to anti-inflammatory and antioxidant activities. -
Drug Intermediate
(S)-2-Methylazetidine hydrochloride is a versatile drug intermediate that plays a crucial role in the synthesis of a variety of biologically active compounds. Its structural properties make it valuable for medicinal chemistry and pharmaceutical research applications. This compound is significant for developing new therapeutic agents and exploring chemical interactions in drug formulation. -
Drug Impurity
Metoprolol Impurity 42 is a known impurity associated with the beta-blocker Metoprolol. This compound is primarily used for analytical research applications to assess drug purity and stability. Its presence may provide insights into the metabolic pathways and degradation products related to Metoprolol, aiding in quality control and regulatory compliance studies. -
Drug Impurity
Ribociclib Impurity 2 is a known impurity associated with the cyclin-dependent kinase 4 and 6 inhibitor Ribociclib. This compound is utilized primarily in the characterization and quantification of drug purity in pharmaceutical formulations. Its presence may affect the pharmacological profile and efficacy of Ribociclib, making it an important compound for quality control and regulatory compliance in drug development and research applications. -
Drug Impurity
Vitamin Impurity 4 is a chemical impurity associated with vitamin compounds, primarily impacting drug safety and efficacy evaluation. This reagent is commonly utilized in quality control assessments within pharmaceutical research, helping to ensure compliance with regulatory standards. Its role as an impurity provides crucial insights into the stability and purity of vitamin formulations, making it an essential tool for researchers involved in vitamin-related studies. -
Drug Impurity
Rebamipide impurity 6 is a known impurity associated with Rebamipide, a therapeutic agent primarily targeting mucosal protection in gastrointestinal disorders. This compound is essential for analytical studies and quality control processes in pharmaceutical research. Its identification and characterization aid in understanding the compound's stability and efficacy profiles. -
Drug Intermediate
3-Methyl-1-tosyl-1H-pyrazol-5-amine serves as a chemical intermediate in the synthesis of diverse active pharmaceutical ingredients. Its structure facilitates modification for the development of compounds exhibiting desired biological activities. This reagent is instrumental in research focused on drug discovery and optimization processes. -
Drug Intermediate
(S)-4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline serves as an important drug intermediate in the synthesis of various active pharmaceutical ingredients. Its unique structural features facilitate diverse modifications for the development of bioactive compounds. This reagent plays a crucial role in medicinal chemistry research, enabling the exploration of potential therapeutic applications. -
Drug Impurity
Vonoprazan impurity 6 is a chemical impurity associated with Vonoprazan, a proton pump inhibitor. It serves as an important reference standard for analytical and quality control purposes in the pharmaceutical industry. The characterization of this impurity aids in ensuring the purity and safety of Vonoprazan formulations, contributing to the rigorous standards of drug development and regulatory compliance. -
Drug Intermediate
21-Chloro-3,6,9,12,15-pentaoxahenicosan-1-ol serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. Its structural attributes facilitate subsequent chemical modifications necessary for the development of pharmaceuticals. This reagent plays a vital role in medicinal chemistry research and can be effectively utilized in the design and synthesis of novel therapeutic agents. -
Drug Intermediate
3-Fluorobutan-1-amine hydrochloride is a valuable drug intermediate that facilitates the synthesis of diverse bioactive compounds. Its structural properties support various chemical modifications, making it essential for research in medicinal chemistry and pharmacology. This reagent is instrumental in developing novel therapeutics and studying biological pathways. -
Drug Impurity
(S)-Ponesimod is a chiral impurity associated with the selective S1P receptor modulator, Ponesimod. Its presence is relevant in the development and quality control of therapeutic formulations targeting autoimmune diseases. Research applications include assessing drug purity and understanding the pharmacokinetics of S1P receptor modulators. -
Drug Intermediate
4-Fluorobenzene-1,3-dicarboxylic acid is a versatile drug intermediate utilized in the synthesis of various active pharmaceutical compounds. This compound serves as a critical building block in the development of drugs, facilitating the introduction of functional groups and structural modifications. Its applications extend to diverse fields within medicinal chemistry, making it an essential reagent for chemical research and development. -
Drug Intermediate
Isopropyl 1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate serves as a crucial intermediate in drug synthesis. This compound is utilized in the development of a variety of bioactive molecules, facilitating research in medicinal chemistry and pharmaceutical development. Its structural complexities contribute to the enhancement of pharmacological profiles in active compounds, paving the way for novel therapeutic agents. -
Drug Intermediate
BOC-(1S,3R)-3-aminocyclopentanecarboxylic acid is a synthetic intermediate that plays a crucial role in pharmaceutical synthesis. This compound provides a versatile building block for the development of novel bioactive molecules, facilitating the creation of potential drug candidates. Its structural properties make it ideal for applications in medicinal chemistry and drug formulation research. -
Drug Intermediate
7-(Benzyloxy)-3,4-dihydronaphthalen-1(2H)-one is a chemical intermediate widely utilized in the synthesis of diverse bioactive compounds. This compound serves as a critical building block in pharmaceutical research and development, facilitating the creation of novel therapeutic agents. Its structural features make it suitable for applications in organic synthesis and medicinal chemistry. -
Drug Intermediate
(E)-4,6-dichloro-2-styrylpyrimidine is a versatile drug intermediate that plays a crucial role in the synthesis of various bioactive compounds. Its unique structural properties facilitate the formation of complex chemical entities, making it a valuable reagent in pharmaceutical research and development. This compound is utilized in the creation of targeted therapeutics, particularly in studies focused on pyrimidine derivatives and their biological activity. -
Drug Intermediate
1-(4-(Trifluoromethoxy)phenyl)piperazine hydrochloride serves as a key drug intermediate in the synthesis of various active pharmaceutical compounds. This reagent is essential for generating complex molecular structures and enhances the development of potential therapeutic agents. Its unique trifluoromethoxy substituent contributes to optimized biological activity across multiple research applications in medicinal chemistry. -
Drug Impurity
Quetiapine impurity 25 is a drug impurity related to Quetiapine, an atypical antipsychotic. This impurity may be utilized in the evaluation of the quality and efficacy of pharmaceutical formulations containing Quetiapine. Its characterization is essential for ensuring compliance with regulatory standards and for understanding the metabolic pathways and potential side effects associated with Quetiapine use in clinical settings. -
Drug Intermediate
GGFG-Exatecan is a synthetic intermediate designed for the development of antibody-drug conjugates (ADCs). This reagent incorporates a glycyl-glycyl-phenylalanyl-glycine tetrapeptide linker fused with the DNA topoisomerase I inhibitor Exatecan, enhancing its therapeutic potential. GGFG-Exatecan is valuable for cancer research, facilitating the investigation of targeted cancer therapies and improving drug delivery systems in oncological studies. -
Drug Intermediate
3-Fluoro-4-methoxybenzaldehyde is a versatile drug intermediate that serves as a key starting material in the synthesis of the fluorinated derivative of Combretastatin A-4, a compound known for its anti-cancer properties. This intermediate enables the development of novel therapeutics in cancer research, thus facilitating the exploration of fluorinated analogs in medicinal chemistry. Its unique structural features provide significant potential for further applications in drug development. -
Drug Intermediate
2-Chloro-4-nitropyridine serves as a versatile drug intermediate, primarily utilized in the synthesis of various organic compounds, including 2-chloro-4-ethoxypyridine and multiple RET kinase inhibitors. Its structural properties make it instrumental in medicinal chemistry and pharmaceutical development, facilitating the creation of targeted therapeutics for a range of biological applications. -
Drug Intermediate
Furfuryl acetate serves as a valuable drug intermediate in organic synthesis. It is utilized in the production of compounds such as 5-acetoxymethyl-2-vinylfuran and 5-hydroxymethyl-2-vinylfuran, which have potential applications in pharmaceuticals. Its role in the synthesis of these derivatives highlights its importance in medicinal chemistry research. -
Methamphetamine Impurity
N-Formylmethamphetamine is identified as an impurity in the synthesis of methamphetamine and serves as a by-product of the Nagai reaction. Its characterization is essential for assessing the purity of methamphetamine samples in research settings. This compound aids in studies focused on understanding synthesis pathways and enhancing analytical methods in forensic toxicology. -
Biochemical Reagent
2,3-Dichlorobiphenyl is a polychlorinated biphenyl (PCB) known for its role as a biochemical reagent. This compound serves as an endocrine disruptor, impacting gonadal differentiation in the model organism Xenopus laevis. Its biological activity makes it valuable for research in environmental toxicology and developmental biology, particularly in studies examining endocrine system interference and its effects on amphibian development. -
SM-102 Impurity
SM-102 N-Oxide is a structural impurity of the lipophilic compound SM-102. As an important byproduct in lipid-based research, it is utilized primarily to investigate the biophysical properties and efficacy of lipid formulations. Its presence can influence the performance characteristics in applications such as gene delivery and RNA therapeutics. -
Corticosteroid
Fluocortolone pivalate is an ester derivative of Fluocortolone and functions as a corticosteroid. It exhibits anti-inflammatory and immunosuppressive properties, making it useful in the study of various skin disorders. This compound enables researchers to investigate corticosteroid mechanisms in dermatological applications and contributes to the understanding of skin inflammation and related conditions. -
Adenosine Derivative
3'-TBS-OMe-Bz-rA is an adenosine derivative that serves as a key intermediate in the synthesis of modified oligonucleotides and other nucleic acid-related compounds. Its structure allows for incorporation into various nucleic acid frameworks, facilitating the study of biological processes involving RNA and DNA. Research applications include the development of therapeutic oligonucleotides and probes for molecular biology studies. -
Drug Intermediate
tert-Butyl 3,9-diazaspiro[5.5]undecane-3-carboxylate serves as a crucial drug intermediate in the synthesis of diverse biologically active compounds. Its unique structural features facilitate the development of pharmaceutical agents with potential therapeutic applications. This compound is instrumental in medicinal chemistry for the creation of novel molecules targeting specific biological pathways.
